Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Neuraminidase | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0046 | 0.0022 | 0.0008 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0046 | 0.0022 | 0.0008 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0134 | 0.0216 | 0.0203 |
Loa Loa (eye worm) | hypothetical protein | 0.4559 | 1 | 1 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0046 | 0.0022 | 1 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0046 | 0.0022 | 1 |
Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 0.4559 | 1 | 1 |
Loa Loa (eye worm) | acetyltransferase | 0.0134 | 0.0216 | 0.0203 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0046 | 0.0022 | 0.0008 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 0.0022 | 1 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0046 | 0.0022 | 0.5 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 0.0022 | 1 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.013 | 0.0208 | 0.0201 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0046 | 0.0022 | 1 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0046 | 0.0022 | 0.5 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 0.0022 | 0.5 |
Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 0.4559 | 1 | 1 |
Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 0.4559 | 1 | 1 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0036 | 0 | 0.5 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.0046 | 0.0022 | 0.0008 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0046 | 0.0022 | 0.0008 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0046 | 0.0022 | 0.0008 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0042 | 0.0014 | 0.0006 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0046 | 0.0022 | 0.5 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0046 | 0.0022 | 1 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0046 | 0.0022 | 0.0015 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0134 | 0.0216 | 0.0203 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0042 | 0.0014 | 0.0006 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0134 | 0.0216 | 0.0203 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5.124 | Inhibition of Influenza virus neuraminidase A | ChEMBL. | No reference |
IC50 (binding) | = 7.5 uM | Inhibition of Influenza virus neuraminidase A | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.